
Biontech Faces Uncertain Future After Job Cuts and Founders' Departure
Biontech CEO Uğur Şahin addressed shareholders regarding upcoming job cuts, but investors appear more concerned about the departure of the founding couple.
4 stories found

Biontech CEO Uğur Şahin addressed shareholders regarding upcoming job cuts, but investors appear more concerned about the departure of the founding couple.

Uğur Şahin and Özlem Türeci, the co-founders of BioNTech, are stepping down from the German pharmaceutical company to pursue a new venture in mRNA technology.

BioNTech founders Uğur Şahin and Özlem Türeci are embarking on a new venture, with their original investors and co-founders, Thomas and Andreas Strüngmann, expressing interest in investing again. This move follows their stepping back from BioNTech's leadership, highlighting their continued focus on scientific innovation and entrepreneurship.

Uğur Şahin és Özlem Türeci új mRNS-startupot alapítanak.